Orthofix Announces FDA Clearance and Initial Patient Implant of the Company’s First 3D-Printed Titanium Cervical Spacer System with Nanovate Technology
Go back to Orthofix Announces FDA Clearance and Initial Patient Implant of the Company’s First 3D-Printed Titanium Cervical Spacer System with Nanovate Technology| Orthofix International NV (NASDAQ: OFIX) | Delayed: 11.79 -0.38 (3.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.17 | 52 Week High | $48.25 | |||
| Open | $11.97 | 52 Week Low | $35.61 | |||
| Day High | $12.14 | P/E | 4.93 | |||
| Day Low | $11.62 | EPS | $2.39 | |||
| Volume | 242,418 | |||||
